950210 fundamentals
An in-depth look to PRESTIGE BIOPHARMA LIMITED KDR operating, investing, and financing activities
950210 free cash flow for Q3 24 is -15.95 B KRW. For 2024, 950210 free cash flow was -68.28 B KRW and operating cash flow was -48.19 B KRW.
Q3 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: KRW
Q3 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM